Medpace Holdings (MEDP) Non Operating Income (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Non Operating Income came in at $4.8 million in Q2 2026, up 369.28% on a YoY basis from $1.0 million in Q2 2025, and down 20.52% quarter-over-quarter from $6.1 million in Q1 2026.
Analysis
Medpace Holdings (MEDP) Non Operating Income (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Non Operating Income for 12 consecutive years, with $4.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non Operating Income rose 369.28% year-over-year to $4.8 million; the trailing twelve-month figure through Jun 2026 stood at $15.5 million (down 13.09% YoY), and the FY2025 full-year result was $7.4 million, down 74.38% from the prior year.
- Non Operating Income eased to $4.8 million in Q2 2026 per MEDP's latest filing, from $6.1 million in the prior quarter.
- Across five years, Non Operating Income topped out at $8.7 million in Q1 2024 and bottomed at -$2.8 million in Q4 2022.
- Historically, Non Operating Income has averaged $2.8 million across 5 years, with a median of $3.5 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Non Operating Income slumped 361.35% in 2022, then jumped 5107.47% in 2024.
- Over 5 years, Non Operating Income stood at -$2.8 million in 2022, then jumped by 221.57% to $3.4 million in 2023, then soared by 151.08% to $8.5 million in 2024, then tumbled by 58.09% to $3.6 million in 2025, then surged by 35.77% to $4.8 million in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered $4.8 million, $6.1 million, and $3.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 4.84 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | - |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 1.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.84 Mn |
| Mar 31, 2026 | 6.09 Mn |
| Dec 31, 2025 | 3.56 Mn |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | -1.80 Mn |
| Mar 31, 2025 | 4.65 Mn |
| Dec 31, 2024 | 8.50 Mn |
| Sep 30, 2024 | 6.50 Mn |
| Jun 30, 2024 | 5.33 Mn |
| Mar 31, 2024 | 8.71 Mn |
| Dec 31, 2023 | 3.39 Mn |
| Sep 30, 2023 | -1.71 Mn |
| Jun 30, 2023 | -2.65 Mn |
| Mar 31, 2023 | -174,000.00 |
| Dec 31, 2022 | -2.79 Mn |
| Sep 30, 2022 | 4.07 Mn |
| Jun 30, 2022 | 1.76 Mn |
| Mar 31, 2022 | 1.12 Mn |
| Dec 31, 2021 | 1.07 Mn |
| Sep 30, 2021 | 1.02 Mn |